SEC Form 4 · accession 0001104659-15-077888
Avalo Therapeutics, Inc. · AVTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Phil Gutry
Director
Period of report
Nov 9, 2015
Accepted (ET)
Nov 12, 2015 · 6:06 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001534120
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $5.80 | Nov 9, 2015 | A | 16,714 | A | — | Oct 31, 2025 | Common Stock | 16,714 | 16,714 | D |
Explanation of responses
- F1The Stock Options vest in three equal installments on November 9, 2016, 2017 and 2018.